Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Human data: caution The only human data published to date are extremely limited: a 2024 pilot trial in 12 patients with interstitial cystitis treated with 10 mg of BPC-157 injected into the bladder wall, and a 2026 pharmacokinetic study in two healthy subjects (one 58-year-old man and one 68-year-old woman) receiving intravenous BPC-157
Reduces oxidative stress, may improve psoriasis, reduces cell damage in alcoholic and nonalcoholic fatty liver disease
It is nevertheless fascinating that cysteine even could deplete glutathione, since glutathione is made from it
Additionally, a cohort study of 371,463 individuals provided genetic evidence that varying alcohol intake levels are linked to a persistent, nonlinear increase in the risk of hypertension and coronary artery disease
